Donate For Public and Patients Store Search

F056 - Late-breaking Research: Procedural Dermatology

Saturday, March 2; 9:00 AM - 11:00 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe ground-breaking scientific developments in dermatologic research.
  • Evaluate and apply information from recent investigations to clinical practice.

Description

Researchers can submit abstracts describing their most recent unpublished results. After a competitive review, the top scoring studies will be invited to discuss their findings in a brief oral presentation during one of the themed sessions. This year, there will be three Forums (clinical/pediatric dermatology, surgery/procedural dermatology and basic science/dermatopathology) and a new Clinical Trials Symposium. Together, these sessions will highlight the latest ground-breaking observations in all aspects of dermatological research.

Disclosures

  • Abdelshafy, Ahmed said, MD, MBBCh, DSc: no financial relationships exist with commercial interests.
  • Alam, Murad, MD: Pulse Biosciences – C(Fees);
  • Bittar, Julie: no financial relationships exist with commercial interests.
  • Cho, Yeorye: no financial relationships exist with commercial interests.
  • Goldust Jouybari, Mohamad, MHS: no financial relationships exist with commercial interests.
  • Juhasz, Margit, MD, MSc: Merz Aesthetics – I(Grants/Research Funding);
  • Kathed, Atul K., MBBS, DVD: no financial relationships exist with commercial interests.
  • Kaufman, Joely, MD: Allergan, Inc – A(H), I(Grants/Research Funding); Alphaeon – SH(NC); Bonti – A(Fees); Cutera, Inc. – SP(H); Endo International plc – I(Grants/Research Funding); Galderma USA – A(H), I(Fees); Lutronics, Inc. – A(H); Merz Pharmaceuticals, LLC – I(Grants/Research Funding); Neothetics – I(Fees); Revance Therapeutics, Inc. – I(Fees); Sienna Biopharmaceuticals – I(Grants/Research Funding); TEOXANE Laboratories – I(Fees);
  • Mourad, Ahmed: no financial relationships exist with commercial interests.
  • Munavalli, Girish S., MD, MHS: BTG PLC – A(H); Candela Corporation – A(H); Covidien – C(H); Lumenis – I(EQ); Merz Aesthetics – A(H);
  • Pourang, Aunna, MD: LearnHealth/LearnSkin – A(NC), Speaker/Faculty Education(H);
  • Tsao, Hensin, MD, PhD: Asana Biosciences, LLC – I(Grants/Research Funding); Epiphany Dermatology – A(H); Massachusetts General Hospital – E(S); Relay Therapeutics – I(Grants/Research Funding); UpToDate, Inc. – O(H); Worldcare Clinical, LLC – C(H);
  • Tsao, Sandy Sharon, MD: no financial relationships exist with commercial interests.
  • Tuan, HsiaoHan, MD, MS: no financial relationships exist with commercial interests.
  • Vedamurthy, Maya, MD: no financial relationships exist with commercial interests.
Schedule
Saturday, March 2
9:00 AM
Cho / A Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy according to the Density of Ablative Laser Channel in the Treatment of Actinic Keratosis
9:10 AM
Goldust Jouybari / Efficacy of Minoxidil 15% Solution Plus Low-Level Light Therapy Versus Low-Level Light Monotherapy in the Treatment of Androgenetic Alopecia
9:20 AM
Dr. Kathed / Treatment of Post Burn/Hypertrophic Scars Using a Non-insulated Smooth Motion, Electronically Controlled Radiofrequency Microneedles System Combined with Intralesional Triamcinolone Acetonide & 5 Fluo
9:30 AM
Mourad / Oral and Intra-incisional Antibiotic Prophylaxis in Mohs Surgery: A systematic review and meta-analysis
9:40 AM
Dr. Abdelshafy / Intralesional Tranexamic Acid Versus Platelet Rich Plasma in Melasma Treatment. A Split Face Comparative Study
9:50 AM
Dr. Munavalli / Safety and Efficacy of Nano-pulse Stimulation in the Treatment of Patients with Sebaceous Hyperplasia
10:00 AM
Bittar / No Local Recurrence for Extramammary Paget’s Disease (EMPD) Treated with Standard and Modified Mohs Micrographic Surgery (MMS) with Immunostaining for Cytokeratin-7: Methodology and report of 20 cases
10:10 AM
Pourang / Running Cutaneous Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis of the Face and Neck: A randomized evaluator blind split-wound comparative effectiveness trial
10:20 AM
Dr. Vedamurthy / Successful Treatment of Vitiligo by Needling with Topical 5 Fluorouracil
10:30 AM
Tuan / A Comparison of the Efficacy and Safety of Fractional CO2 Laser and Fractional Er:YAG Laser for the Treatment of Xanthelasma Palpebrarum : A multicenter randomized split-face controlled trial
10:40 AM
Dr. Kaufman / Two Randomized, Double-Blind, Placebo-Controlled, Phase 3, Trials of Collagenase Clostridium Histolyticum (CCH) for the Treatment of Cellulite (Edematous Fibrosclerotic Panniculopathy)
10:50 AM
Juhasz / Fractional Photothermolysis Stimulates Hair Follicle Regrwoth in Alopecia Patients - A pilot study
Event Details
  • Date
    Saturday, March 2
  • Time
    9:00 AM - 11:00 AM
  • Location
    Salon H
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
Speakers
  • Ahmed Mourad
  • Ahmed said Abdelshafy, MD, MBBCh, DSc - Handout
  • Atul K. Kathed, MBBS, DVD - Handout
  • Aunna Pourang, MD - Handout
  • Girish S. Munavalli, MD, MHS, FAAD
  • HsiaoHan Tuan, MD, MS - Handout
  • Joely Kaufman, MD, FAAD
  • Julie Bittar
  • Margit Juhasz, MD, MSc
  • Maya Vedamurthy, MD
  • Mohamad Goldust Jouybari, MHS
  • Murad Alam, MD, FAAD
  • Sandy Sharon Tsao, MD, FAAD
  • Yeorye Cho - Handout